Wednesday, September 28, 2022

Buy now

COVAXIN now a universal vaccine for adults and children: Bharat Biotech

[ad_1]

COVAXIN now a universal vaccine for adults and children: Bharat Biotech


Representational Image.&nbsp | &nbspPhoto Credit:&nbspPTI

Key Highlights

  • Covaxin accounts for 12 per cent of the total Covid-19 vaccines administered in India so far since January 2021

  • The announcement comes on the day Bharat Biotech urged the Drugs Controller General of India to give a regular market approval for its Covid-19 vaccine

New Delhi: In a major breakthrough for India, indigenously-developed anti-coronavirus vaccine – Covaxin – has now been recognised globally as a “universal vaccine for adults and children”.

“Covaxin is now a universal vaccine for adults and children. Our goals of developing a global vaccine against Covid-19 have been achieved and all product development for licensure has been completed,” its manufacturer Bharat Biotech said in a statement on Thursday, according to news agency ANI.

As per the latest available data, Covaxin accounts for 12 per cent of the total Covid-19 vaccines administered in India so far since January 2021.

Moreover, Covaxin is the only Covid-19 vaccine administered to youngsters in the age-group of 15-18 years, the vaccination programme for whom began on January 3.

The announcement comes on the day the Hyderabad-based Indian pharmaceutical company urged the Drugs Controller General of India (DCGI) to give a regular market approval for its Covid-19 vaccine.

“Bharat Biotech International Limited (BBIL) took up the challenge to develop, produce and clinically evaluate a COVID-19 vaccine (Covaxin), from the SARS-CoV-2 strains isolated from COVID-19 patients in India, Mohan said in the application. It was granted the permission to manufacture Covaxin for restricted use in emergency situations on January 3. In the current submission, all the required complete information regarding chemistry, manufacturing and controls, along with the pre-clinical and clinical data have been provided in five modules. The information contained in the modules is uploaded on SUGAM portal for your kind perusal. We request you to kindly review the same and grant the marketing authorisation, at the earliest,” V Krishna Mohan, a top Bharat Biotech official, wrote in his application to DCGI.

[ad_2]

Source link

Related Articles

Stay Connected

0FansLike
3,506FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles